| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 1,209,300 | 1,157,100 | 1,036,000 | 994,200 |
| Cost of sales | 477,900 | 468,300 | 447,000 | 400,400 |
| Gross profit | 731,400 | 688,800 | 589,000 | 593,800 |
| Research and development | 157,500 | 148,200 | 145,200 | 135,400 |
| Selling, general and administrative | 331,400 | 328,000 | 310,100 | 306,400 |
| Total operating expenses | 488,900 | 476,200 | 455,300 | 441,800 |
| Operating income | 242,500 | 212,600 | 133,700 | 152,000 |
| Other income, net | 109,800 | 28,500 | 20,600 | 25,400 |
| Income before income taxes | 352,300 | 241,100 | 154,300 | 177,400 |
| Income tax expense | 68,500 | 61,300 | 48,900 | 42,800 |
| Net income | 283,800 | 179,800 | 105,400 | 134,600 |
| Basic net income per share (in usd per share) | 0.73 | 0.46 | 0.27 | 0.34 |
| Diluted net income per share (in usd per share) | 0.7 | 0.45 | 0.27 | 0.34 |
| Shares used to compute basic net income per share (in shares) | 391,100,000 | 392,100,000 | 391,100,000 | 394,200,000 |
| Shares used to compute diluted net income per share (in shares) | 407,400,000 | 408,200,000 | 407,500,000 | 410,200,000 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)